Azenta
AZTA
35.89
-3.46
-8.79%
Azenta
US · AZTA
#2893 by market cap
Listed 1970
35.89
-3.46
-8.79%
Live - 5344 symbols - heartbeat 140s ago
· 2026-10-08 08:29
Pre-market
35.75
-0.39%
After-hours
36.32
+1.20%
Overnight
35.89
0.00%
- Market cap
- 1.57B
- P/E (TTM)i
- -13.34
- P/Bi
- 1.04
- EPSi
- -1.22
- Div yieldi
- 0.00%
- 52W posi
- 65%
Reader sentiment
Are you bullish or bearish on AZTA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- Total institutional ownership rose 0.5 percentage points.
Institutional ownership
- Held by institutions
- 115.88% +0.49pp
- Institutions
- 298
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund84.34%
Hedge Fund21.66%
Public Company5.26%
Government Pension Fund1.90%
Private Company1.08%
Insurance Company0.98%
Individual/Insider0.67%
Sovereign Wealth Fund0.49%
Family Office/Trust0.13%
Top holders as of 2026-06-30
BlackRock
17.19% · 7.53M sh
Politan Capital Management, L.P.
10.55% · 4.62M sh
Vanguard Portfolio Management, LLC
5.69% · 2.49M sh
Vanguard Capital Management, LLC
4.89% · 2.14M sh
State Street Global Advisors
4.25% · 1.86M sh
MFS Investment Management
3.25% · 1.42M sh
D. E. Shaw & Co., L.P.
3.06% · 1.34M sh
Front Street Capital Management, Inc.
2.97% · 1.30M sh
Dimensional Fund Advisors
2.81% · 1.23M sh
Allspring Global Investments, LLC
2.72% · 1.19M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 38 buys · 12 sells
| Name | Role | Stake |
|---|---|---|
| Politan Capital Management, L.P. | -- | 10.55% |
| Martin Madaus | Independent Director | 0.10% |
| Robyn Davis | Independent Director | 0.09% |
| John P. Marotta | President | 0.09% |
| Lawrence Lin | Chief Financial Officer | 0.06% |
| Erica McLaughlin | Independent Director | 0.05% |
| Frank Casal | Independent Director | 0.05% |
| William Cornog | Independent Director | 0.04% |
| Alan Malus | Independent Director | 0.04% |
| Tina Nova | Independent Director | 0.04% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-21 | Martin Madaus | Independent Director | Sale to Issuer | -1,456 | $34.28 |
| 2026-09-14 | Erik Bello | Vice President, Chief Accounting Officer & Principal Accounting Officer | Other Acquisition | +4,586 | -- |
| 2026-09-13 | Martin Madaus | Independent Director | Other Acquisition | +36,653 | -- |
| 2026-09-13 | Ephraim Starr | Senior Vice President | Other Acquisition | +15,272 | -- |
| 2026-09-13 | Olga Pirogova | Senior VP & Chief HR Officer | Other Acquisition | +15,272 | -- |
| 2026-09-13 | William Martin | President of Multiomics Business | Other Acquisition | +15,272 | -- |
| 2026-09-13 | Lawrence Lin | Chief Financial Officer | Other Acquisition | +30,544 | -- |
| 2026-08-08 | Olga Pirogova | Senior VP & Chief HR Officer | Sale to Issuer | -1,085 | $32.04 |
| 2026-07-30 | Ephraim Starr | Senior Vice President | Private Acquisition | +335 | $24.17 |
| 2026-05-17 | William Cornog | Independent Director | Open Market Acquisition | +10,000 | $16.38 |
| 2026-05-14 | Ephraim Starr | Senior Vice President | Sale to Issuer | -3,621 | $16.02 |
| 2026-04-27 | William Martin | President of Multiomics Business | Other Acquisition | +17,790 | $24.24 |
| 2026-02-05 | Tina Nova | Independent Director | Other Acquisition | +5,663 | $27.85 |
| 2026-02-04 | Martin Madaus | Independent Director | Other Derivative Acquisition | +5,663 | -- |
| 2026-02-04 | Robyn Davis | Independent Director | Other Derivative Acquisition | +5,663 | -- |
| 2026-02-04 | Erica McLaughlin | Independent Director | Other Acquisition | +5,663 | $27.85 |
| 2026-02-04 | Dipal Doshi | Independent Director | Other Acquisition | +5,663 | $27.85 |
| 2026-02-04 | Frank Casal | Independent Director | Other Acquisition | +7,243 | $27.85 |
| 2026-02-04 | Quentin Koffey | Independent Director | Other Acquisition | +5,663 | -- |
| 2025-11-23 | Ephraim Starr | Senior Vice President | Other Acquisition | +34,235 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:29:15 · For reference only, not investment advice and not tailored to your situation.